EurekAlert! - Infectious and Emerging Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Kansas State University virologists publish new findings on SARS-CoV-2 treatment option
(Kansas State University) A recent study by Kansas State University virologists demonstrates successful post-infection treatment for SARS-CoV-2, the virus that causes COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 2, 2021 Category: Infectious Diseases Source Type: news

Only 20 states used health equity committees in COVID-19 vaccine distribution planning
(University of Chicago Medical Center) A new study found that while 43 states (out of 51, including all 50 states and Washington, D.C.) created a committee to develop a vaccine distribution plan, only 20 plans mentioned using a health equity committee to assist with plan development. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 2, 2021 Category: Infectious Diseases Source Type: news

Lottery-based incentives do not increase COVID-19 vaccination rates
(Boston University School of Medicine) Would you be more willing to get vaccinated against the COVID-19 virus if you could participate in a lottery for cash and prizes? The answer was surprisingly no, according to Boston University School of Medicine (BUSM) researchers who found that Ohio's " Vax-a-Million " lottery-based incentive system, intended to increase COVID-19 vaccination rates, was not associated with an increase in COVD-19 vaccinations. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 2, 2021 Category: Infectious Diseases Source Type: news

Researchers find potential path to a broadly protective COVID-19 vaccine using T cells
(Massachusetts General Hospital) Using a method developed for HIV, researchers have identified stable T cell vaccine targets in SARS-CoV-2. These stable targets, known as highly networked epitopes, are highly likely to be stable in different variants of the virus. The results provide a path forward for a broadly protective COVID-19 T cell vaccine. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 2, 2021 Category: Infectious Diseases Source Type: news

Large-scale drug analysis reveals potential new COVID-19 antivirals
(The Francis Crick Institute) Researchers at the Francis Crick Institute and University of Dundee have screened thousands of drug and chemical molecules and identified a range of potential antivirals that could be developed into new treatments for COVID-19 or in preparation for future coronavirus outbreaks. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection
(Institute for Basic Science) SARS-CoV-2 replication targets nasal ciliated cells early in COVID-19 infection. The establishment of nasal mucosal immunity against SARS-CoV-2 through a nasal vaccine could be the most efficient way to combat COVID-19 infection. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

COVID-19 aggravates antibiotic misuse in India
(Washington University in St. Louis) Antibiotic sales soared during India's first surge of COVID-19, suggesting that the drugs were inappropriately used to treat mild and moderate COVID-19 infections, according to research led by Washington University School of Medicine in St. Louis. The excessive usage is especially concerning because antibiotic overuse increases the risk for drug-resistant infections -- not just in India, but worldwide. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

Hi-tech lab to boost COVID-19 diagnostic capability, prepare for future pandemics
(Nanyang Technological University) Nanyang Technological University, Singapore (NTU Singapore) and Pathnova Laboratories, a medical diagnostic company backed by Temasek Life Sciences Accelerator and headquartered in Temasek Life Sciences Laboratory, is contributing to Singapore's COVID-19 diagnostic capability through its partnership in a new clinical diagnostic laboratory. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

Study with healthcare workers supports that immunity to SARS-CoV-2 is long-lasting
(Barcelona Institute for Global Health (ISGlobal)) One year after infection by SARS-CoV-2, most people maintain anti-Spike antibodies regardless of the severity of their symptoms, according to a study with healthcare workers co-led by ISGlobal, the Catalan Health Institute and the IDIAP JG. The results suggest that vaccine-generated immunity will also be long-lasting. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

FAPESP webinar will discuss how SARS-COV-2 affects the human brain
(Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo) Renowned scientists will focus on COVID's impact on the human brain addressing molecular mechanisms from both cellular and organismal viewpoints. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

Chasing the cells that predict death from severe COVID-19
(Gladstone Institutes) By studying T cells, a team of scientists at Gladstone Institutes has uncovered fundamental differences between patients who overcome severe COVID-19 and those who succumb to it. The team also found that dying patients harbor relatively large numbers of T cells able to infiltrate the lung, which may contribute to the extensive lung deterioration that is a hallmark of fatal COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

Mefloquine: A promising drug 'soldier' in the battle against COVID-19
(Tokyo University of Science) In the 'war' that the world has been fighting against COVID-19, scientists have been scanning their arsenals of previously used drugs in hopes of finding any that can be used to treat the disease. One of the contenders under scrutiny, an anti-malarial drug called mefloquine shows great promise, according to a new breakthrough study by a team of Japanese scientists, perhaps giving us a better fighting chance. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

For transplant patients, COVID-19 vaccination presents a different uncertainty
(University of California - San Diego) Researchers at UC San Diego Health have launched a pair of clinical trials to study the immune response of COVID-19 vaccinated transplant recipients of bone marrow and solid organs, such as the heart, lung, liver and kidney. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

Moderna and Pfizer-BioNTech vaccines prime T cells to fight SARS-CoV-2 variants
(La Jolla Institute for Immunology) Researchers at La Jolla Institute for Immunology (LJI) have found that T cells from people who have recovered from COVID-19 or received the Moderna or Pfizer-BioNTech vaccines are still able to recognize several concerning SARS-CoV-2 variants. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news

Vaccines grown in eggs induce antibody response against an egg-associated glycan
(University of Chicago Medical Center) Researchers have found that viral vaccines grown in eggs, such as the H1N1 flu vaccine, produce an antibody response against a sugar molecule found in eggs, which could have implications for the effectiveness of these vaccines. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 1, 2021 Category: Infectious Diseases Source Type: news